HALIFAX, Nova Scotia –January 4, 2015 -- Athletigen Technologies Inc., a sports genetics company, today announced it has raised US$1.55M in seed funding to propel the growth of the Athletigen Performance Platform - a tool used by elite athletes, including professionals and Rio 2016 Olympians, and their coaches. The financing was led by Exponential Partners, a venture capital fund specializing in the application of breakthrough technologies in consumer health and human performance.
